ProShare Advisors LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$130,000
+32.7%
28,146
+0.5%
0.00%0.0%
Q4 2018$98,000
-71.0%
28,009
-16.6%
0.00%
-50.0%
Q3 2018$338,000
+35.2%
33,567
-2.9%
0.00%0.0%
Q2 2018$250,000
+11.6%
34,561
-6.6%
0.00%
+100.0%
Q1 2018$224,000
-45.9%
37,019
-14.0%
0.00%
-66.7%
Q4 2017$414,000
+9.5%
43,066
+1.1%
0.00%0.0%
Q3 2017$378,000
-23.6%
42,596
+8.8%
0.00%
-40.0%
Q2 2017$495,000
+14.8%
39,145
-4.5%
0.01%0.0%
Q1 2017$431,000
-8.5%
41,009
-19.9%
0.01%0.0%
Q4 2016$471,000
-15.9%
51,188
+7.8%
0.01%
-37.5%
Q3 2016$560,000
-22.9%
47,475
-15.4%
0.01%
-11.1%
Q2 2016$726,000
-18.6%
56,136
+0.6%
0.01%
-25.0%
Q1 2016$892,000
-49.2%
55,805
-9.0%
0.01%
-42.9%
Q4 2015$1,757,000
+8.2%
61,353
+7.5%
0.02%
-8.7%
Q3 2015$1,624,000
-24.7%
57,048
-5.0%
0.02%
-23.3%
Q2 2015$2,157,000
+23.3%
60,041
+99.5%
0.03%
+42.9%
Q1 2015$1,749,000
+64.1%
30,094
+19.0%
0.02%
+75.0%
Q4 2014$1,066,000
+26.5%
25,296
+16.3%
0.01%
+9.1%
Q3 2014$843,000
+5.2%
21,747
-15.2%
0.01%
+10.0%
Q2 2014$801,000
-40.3%
25,650
-20.7%
0.01%
-41.2%
Q1 2014$1,341,000
+253.8%
32,357
+230.3%
0.02%
+183.3%
Q4 2013$379,0009,7950.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders